Description and Brand Names
药物信息提供方:IBM Micromedex
US Brand Name
- Unituxin
Descriptions
Dinutuximab injection is used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), to treat children with high-risk neuroblastoma (a type of cancer that most often occurs in young children). This medicine is a GD2-binding monoclonal antibody.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2022
版权 © 2020 IBM Watson Health。保留所有权利。信息仅供终端用户使用,不得出售、重新分发或用于其他商业目的。